Earnings History Data for Hemab Therapeutics Holdings, Inc. (COAG) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings Inc. is a clinical-stage biotechnology company developing therapies which reimagine the treatment of blood coagulation disorders to sustain life and human resilience. Hemab Therapeutics Holdings Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-08-2026 | PM | COAG | Hemab Therapeutics Holdings, Inc. | 2,319 | -0.80 | -0.63 | 0.00 | 51.55 | 1.68 (3.37%) |
49.87 | 0.0 (0.00%) |
23.00 - 53.61 | 224,564 | 470,000 | 7,596 | |||
|
|
||||||||||||||||||